February 2022 For quick navigation, please click on the titles below of the topics featured in this month's issue of Connections. Research Quitlines Tobacco CessationPriority PopulationsE-Cigarettes and Heated Tobacco ProductsTechnologyTobacco UseCOVID-19Job and Conference Announcements
NAQC News
March 1 Deadline: Call for Nominations for NAQC Board of Directors. The North American Quitline Consortium (NAQC) invites its members and partners to recommend qualified candidates for the Board of Directors. All nominations must be received by Miranda Spitznagle, Chair of the Nomination Committee, c/o Board@naquitline.org by March 1.
NAQC is seeking to add one person to the Board of Directors. We are counting on you to help us find outstanding candidates again this year. You are welcome to recommend names of new candidates as well as candidates nominated in past years. You can find a list of current board members here and detailed information on the election process here. The NAQC board is responsible for governing the organization and fiduciary activities. The Board helps ensure NAQC’s advancement and sustainability. QUALIFICATIONS: Quitlines are experiencing many changes, reflected in the emergence of new technologies, service models, approaches to sustainability, and populations served. NAQC seeks candidates for the Board who are innovative “difference makers” and who can help guide us through these changes. NAQC follows a policy governance model developed by John Carver that focuses on business issues and strategic leadership, rather than program development. Candidates for the board should:- Have senior level corporate experience
- Possess leadership skills
- Be strategic thinkers
- Display professional and collegial demeanor
Board members do not represent their employer or any specific constituency, but instead work together to create a global vision for NAQC. We strive to have a Board that is diverse in terms of geography, race, ethnicity, gender, and perspective. The Board seeks members who are committed to NAQC’s mission and values, contribute diverse viewpoints and cultural experiences, and/or can fulfill fiduciary responsibilities. Board members may have expertise in areas such as: financial/fiduciary responsibility; sustainability of quitlines and of NAQC; addressing disparities in health; interests of NAQC membership; and relationships with health plans and employers.
Board members are elected for 3-year terms and can be reelected (or reappointed) once for a total of six years of service. The annual time commitment for board members includes four meetings (usually 2 in-person meetings and 2 virtual meetings, but now all 4 meetings are being held virtually) plus meeting preparation time, travel time and 2-10 hours of committee work. We ask directors to support the cost of their travel to Board meetings, if this is an expense their employer will allow.
For each person you would like to recommend, please provide the following information to Miranda Spitznagle, Chair of the Nomination Committee, c/o Board@naquitline.org by March 1.
1. Full name, contact information and brief resume for the person; 2. Your rationale for recommending this person as a candidate; and 3. Confirmation that you have spoken to the person and know that s/he is willing to have her/his name put forward to the Nomination Committee for consideration.
March 2 Webinar: Implications of Cannabis Legalization for Quitlines. This webinar will discuss the implications of cannabis legalization for quitlines. A panel of presenters will share an overview of the current cannabis landscape. The webinar will also highlight ways that tobacco control and cannabis regulatory staff can coordinate activities.Objectives: By the end of the webinar, participants will: - Understand the state and federal landscape for cannabis policy
- Learn about cessation needs and services for cannabis
- Hear ideas on appropriate ways for state tobacco control and cessation staff and cannabis regulatory staff to stay informed and coordinate activities.
» register today
June 1, 8, 15: Hold the Dates for NAQC pre-NCTOH Workshops and Reception in New Orleans! NAQC will host three virtual pre-NCTOH workshops on June 1, 8 and 15 from 2-4:30 ET (at no cost) and also plans to host a networking reception in New Orleans early evening of June 27th. Additional details on topics and registration will be provided in April.
NAQC Quitline Profiles – Update for State Cessation Managers. Please take a minute to update your state’s quitline profile! Information from NAQC’s Quitline Profiles is used as part of the annual survey analysis. We ask that each state review its quitline profile to make sure the information is up-to-date. If you need assistance with making changes to your state’s quitline profile please contact Natalia Gromov at ngromov@naquitline.org.
NAQC's Membership Drive will Launch in March. NAQC’s membership drive for fiscal year 2022 will begin in early March and we hope all of you will renew your membership for the coming year! To avoid a lapse in your membership benefits, please submit payment for your dues before July 1, 2022 (payments are accepted in a form of a check, credit card payment, and online renewal). Please refer to the membership page for more information.
Please contact NAQC if you would like to participate in an orientation/refresher webinar to learn more about how to get the most from your membership in NAQC!
For questions regarding membership and benefits, please contact Natalia Gromov at 800-398-5489 ext. 701 or membership@naquitline.org.
NAQC Webinar (Recording Available): Innovative Strategies to Promote Quitlines During the Pandemic. This webinar highlighted innovative practices for promoting quitlines during the pandemic. The Smoking Cessation Leadership Center shared resources available through the I COVID Quit campaign. The webinar will also feature a state presentation on using the I COVID Quit campaign and other promotional strategies to increase call volume. The objectives of this webinar included:- To present innovative practices for promoting quitlines
- To feature free resources available from the I COVID Quit campaign
- To share how states are using social media and other promotional strategies to increase call volume
Slides Recording (Passcode: +agD%+x4) Find more NAQC News in our Newsroom or go back to top.
Time-Sensitive News
The Tobacco Online Policy Seminar (TOPS) 2021-2022 Fall/Winter Series. The Tobacco Online Policy Seminar (TOPS) is a free multidisciplinary, international forum for research with tobacco policy implications using experimental or quasi-experimental study designs (i.e., with a well-defined counterfactual). TOPS strives to be a respectful, inclusive, and diverse forum, with participants and attendees united around the concept of presenting and learning from tobacco research using study designs capable of producing results with a causal interpretation, with the ultimate goal being the production and sharing of knowledge to develop an effective tobacco policy framework for improving population health. This forum is designed to bring together academics, students, government employees, policy researchers, healthcare professionals, advocates, and funders, with the goal of breaking silos in tobacco policy research and providing a platform for high-quality research to be discussed and disseminated.
The following is the Winter schedule (Fridays, 12-1PM ET) February 18, 2022 Dan Sacks, Inidiana University “Cigarette Taxes, Smoking, and Health in the Long Run” Dan Sacks is an Associate Professor and Weimer Faculty Fellow in the Business Economics and Public Policy Department, Kelley School of Business. He received his Ph.D. in Applied Economics from the Wharton School at the University of Pennsylvania. His research spans health economics, public finance, and industrial organization. In recent work he studies the dynamics of addiction in opioids and nicotine, with a focus on understanding how policy can deter new initiation. March 4, 2022 Aryn Philips, Northwestern University “Cigarettes Smoked Following CVS Health’s Tobacco-Free Pharmacy Policy”
Monday, February 28th: Deadline to submit abstracts/papers for TOPS Spring 2022. » register now.
Upcoming Tobacco Cessation Coverage & Health Systems Change Cohort Opportunity. The American Lung Association is planning their next cohort call series around utilizing clinical care extenders in healthcare settings to increase capacity and access to evidence-based tobacco treatment services.
This opportunity is open to State Tobacco Control Program Staff and their community partners working on furthering tobacco cessation through coverage policy & systems change. This cohort will include 60-minute virtual meetings:
- Thursday, February 10th, 2022 at 1:00 -2:00p CST
- Thursday, February 24th, 2022 at 1:00 -2:00p CST
Additional Info: For the purpose of this cohort, we are defining “clinical care extenders” as non-physician professionals working in healthcare settings, that may be able to provide any of the following related to cessation: brief tobacco intervention; referral to treatment services; cessation counseling services; and in some cases, prescribe FDA-approved quit medications. Examples of “clinical care extenders” include, but are not limited to: pharmacists, patient navigators (such as oncology nurse navigators), certified tobacco treatment specialists (such as those used to conduct inpatient bedside consults among all patients identified as tobacco users admitted to hospitals), community health workers in clinical settings (working in FQHCs or community care clinics) and dental and oral health providers (dentists and dental hygienists).If you have any questions around your work with tobacco cessation coverage and/or health systems change – please do not hesitate to contact the Lung Association at CessationTA@Lung.org.
Virtual Training - Rutgers Center for Tobacco Studies in Collaboration with the Division of Addiction Psychiatry And co Provided with Rutgers University Behavioral Health Care. Virtual 2-Day Certified Tobacco Treatment Specialist Training FEBRUARY 28-MARCH 1, 2022 Course starts at 8:00am and runs till 5:30pm ET on both dates. Visit www.tobaccoprogram.org for registration details. Please note that registration closed on February 4, 2022.
The training format is virtual and encompasses both asynchronous (working with online materials at your own pace) and synchronous (working virtually together as a group) sections. The asynchronous portion will be conducted through the Canvas online platform in which participants independently complete a series of educational modules during the two weeks prior to our live, 2-day interactive Zoom sessions, February 28-March 1, 2022 from 8:00am-5:30pm ET. This hybrid-approach allows busy professionals much needed schedule flexibility. The Rutgers Center for Tobacco Studies has developed this training to prepare health professionals to provide intensive specialist treatment for tobacco dependence. The nationally recognized faculty brings a wealth of expertise in tobacco control, nicotine addiction, medical consequences of tobacco use, treatment of tobacco dependence, program development and evaluation, and treating tobacco addiction with special populations such as those with mental illness and medical co-morbidities. The training format allows for an interactive and comprehensive educational experience. Participants can expect to leave the training competent to effectively treat patients for tobacco dependence and to provide other services that will help organizations to address tobacco use. The CTTS training meets all of the requirements set forth in the US Public Health Service Guidelines as well as the standards for competencies for tobacco treatment specialists developed by the Association for the Treatment of Tobacco Use and Dependence (ATTUD) and is Accredited by the Council for Tobacco Treatment Training Programs (CTTTP). Objectives: At the end of this training participants will be able to: - Describe the impact that tobacco use, the tobacco industry, and FDA regulation has on society
- Describe the individual impact that tobacco use has on health and addiction, co-morbidities and special populations
- Assess critical factors used in the development of a tobacco treatment plan including motivation and dependence
- Examine how to implement components of a comprehensive, evidence-based tobacco dependence treatment intervention including behavioral skills, social support, and pharmacotherapy, community outreach and cultural sensitivity
- Practice and demonstrate the skills needed to conduct a clinical assessment, engage in individual counseling, motivational interviewing, and group counseling
- Discuss the principals involved in tobacco treatment program development and evaluation, clinical practice guidelines, and evidence-based scientific literature.
» register now
Oklahoma and Colorado 2/28/2022 Deadline Reminder: Telligen Community Initiative's 2022 Funding Priorities. For the past several years, Telligen Community Initiative (TCI) has focused its grantmaking on three priority areas - social determinants of health/health equity, healthcare workforce development and health innovation. In 2022, they will be reducing our funding priorities to two areas:- Social determinants of health/Health equity
- Healthcare workforce development
TCI's decision to end our health innovation funding priority is not meant to convey a lesser importance on uniqueness and innovation. However, it does call into greater focus the need to intentionally create additional resources for the greatest emerging needs in the two priority areas, especially in the healthcare workforce development area as we face an ever-growing shortage of qualified healthcare workers.
The one-step application process through the 2022 RFP will remain the same. The online portal on the webpage supports this streamlined process and TCI staff are available to discuss your project further as well as answer any questions. Please contact them by calling 515-554-2908 or emailing mmcgarvey@telligenci.org.
March 15: SCRIPT (Smoking Cessation or Reduction in Pregnancy Treatment) Virtual Training. SCRIPT via Society for Public Health Education (SOPHE) is an evidence-based program designed to help pregnant smokers quit. It is geared for the clinic or home visit settings and has proven to be easy to implement and is effective. SCRIPT training will be available through open enrollment for March 15, 2022 and the information on registration and cost is included under the URL below. » learn more
March 30 WEBINAR: Smoke-Free Tribal Housing Policies. The National Native Network with the Indian health Service Clinical Support Center (Accredited Provider) present a webinar. Date: Wednesday, March 30, 2022 Time: 3 - 4 p.m., EDT Register: https://tinyurl.com/SmokeFreeHousingWebinar Learning Objectives/Outcomes: At the conclusion of this activity, the healthcare team will be able to: 1. Identify the risks of smoking in multi-unit tribal housing, as well as the benefits of going smoke-free. 2. Examine policy options to consider when adopting a smoke-free tribal housing policy. 3. Locate helpful resources for smoke-free multi-unit tribal housing community awareness campaigns. Target Audience: Physicians, nurses, health educators, administrators, and support staff working with American Indian and/or Alaska Native communities. Presenters: Mike Freiberg, J.D. Senior Staff Attorney Public Health Law Center
Colin Welker, BS, CHES Policy Analyst Public Health Law Center » register now April 27, 28 Virtual Conference: 3rd Annual Teaching Cannabis Awareness & Prevention Conference: A Focus on the Triangulum of Cannabis, Tobacco, and Vaping. Who should attend? Educators, Tupe coordinators, community-based organizations, school administrators, healthcare providers, school resource officers, parents and anyone else working with youth to learn about the latest research on youth & cannabis, including products being used, reasons for use, health effects, and the latest available lessons for teaching cannabis education and prevention to middle and high school aged youth. April 27th-28th, 2022 8AM-12:30PM PST » register now Find more Time-Sensitive News in our Newsroom or go back to top.
Cessation and Tobacco Control News Tips® 2022 Update. The 2022 Tips From Former Smokers Campaign media buy is anticipated to launch on Monday, February 28, and will run through September 25th. The TV buy will be “off air” the weeks of Memorial Day, 4th of July and Labor Day. The new Tips TV ads feature three participants first introduced in the 2020 Tips campaign: Rebecca C., Tonya M., and Michael F. TV ads will be placed nationally. Ads will also run nationally on digital properties. Similar to previous years, promotions are planned for nicotine replacement therapy (NRT). Additional media will be placed on a variety of channels that are highly used by priority populations, including TV, print, streaming audio, and digital. In addition to promoting the 1-800-QUIT-NOW telephone-based counseling service, the Tips campaign will now also be promoting text messaging services, available in English and Spanish, designed to connect people with text-message based support to help them quit smoking. The texting portal, developed in collaboration with the National Cancer Institute, will connect people to state resources or route them to NCI’s SmokefreeTXT if text messaging services are not available in their state. CDC will promote the portal on YouTube during the Tips media buy. Nicotine Replacement Therapy (NRT) will run on 7 weeks of the campaign. Special promotions are planned for Spanish-language speakers and the Asian Smokers Quitline.
February is Black History Month. February is officially Black History Month and a perfect time to remind ourselves and those we work with that smoking is a social justice issue with many proven instances of the industry target marketing to marginalized populations. A new study (linked here) Sociodemographic Disparities in Tobacco Retailer Density in the United States, 2000 – 2017,” in Nicotine and Tobacco Research examines this ongoing practice and findings may help identify which communities should be prioritized for policy intervention and regulation Also, visit Truth Initiative to learn more about the history of the tobacco industry’s target marketing practices. » learn more
Download this FREE Tobacco Control Resource! The Center for Black Health & Equity has created this free tool that will help guide you through this fascinating piece of Black History. To address health disparities impacting African Americans, it is critical to understand and deeply appreciate the relationship between tobacco and descendants of enslaved people; more importantly, we must all understand the tobacco industry in today’s context of predatory marketing, disinvested communities and persistent racism. The Health Justice guide features scientific research and detailed history worth digging into. It also includes in-depth, practical instruction on how to use a community-model to effect policy change.
The FDA proposed a ban on mentholated tobacco in 2021, providing hope for African Americans wanting a smoke-free environment. Learn about the past, present and possible future of this tainted relationship between African Americans and tobacco now! » learn more
CMS Medicare Lung Cancer Screening Decision Memo. CMS announced their Medicare national coverage determination for lung cancer screening and will cover individuals aged 50- 77, with a 20 year pack history. Additionally, they have kept the shared decision making visit, which includes tobacco cessation counseling/ intervention.
The national coverage determination memo from CMS can be reviewed here.
NAQC Encourages State Quitlines to Participate in DOD’s Tobacco Cessation Support Locator! YouCanQuit2 is the Defense Department's campaign to help U.S. Service members quit all forms of tobacco in order to improve health, well-being, and military readiness. Originally launched in 2007, the campaign provides information, motivation, and support to stay or become tobacco free using tools such as the interactive YouCanQuit2 Quit Plan, 24/7 Quit Tobacco Live Chat, and a savings calculator as well as website articles, content, and social media (Facebook, Instagram, and Twitter). While the campaign primarily targets Service members, it can be used across audiences including the families of Service members. Because of frequent deployments and moves, and a population located world-wide, YouCanQuit2 recently launched a Support Locator to make it easy for Service members and others to find resources and support for a variety of tobacco cessation needs. Users can filter search results by geographic location, Military Base, Military Service, type of support, or type of tobacco product to find a program that meets their specific needs. We are reaching out to request submissions from quitlines. Programs and services can submit a resource here; resources must be free and available to Service members and/or their family members. Submissions will be reviewed regularly for publication. If there are any questions, please reach to Dr. Brandi Alford at brandi.n.alford.ctr@mail.mil.
Smoking and Vaping in Young People’s Favorite Shows isn’t just Rampant, it’s Often Glamorized, too. Out of 114 total streaming episodes with tobacco, only one could be classified as anti-smoking, according to research findings. Half were pro-smoking, meaning coders who reviewed the shows noted that tobacco was portrayed in ways that associated the products with themes like wealth, power, success, fun, harmlessness, rebellion, or glamor. » learn more Music Videos Popular with Young People Frequently Feature Tobacco Imagery. Find out how music videos, which were examined for the first time in the latest Truth Initiative® report on tobacco imagery across screens, are a major pop culture influence and prove to be common sources of smoking or vaping depictions. » learn more
American Lung Association's "State of Tobacco Control". ALA’s 20th annual “State of Tobacco Control” report is now available on the ALA website. This report evaluates states and the federal government on tobacco control laws and policies. This year’s report shows significant progress in reducing tobacco use over the past 20 years, but also highlights threats to that progress. » learn more
SCLC's I COVID QUIT Social Media Campaign. The Smoking Cessation Leadership Center (SCLC) of University of California San Francisco (UCSF) launched a national social media marketing campaign in March 2021 to promote smoking cessation among people with behavioral health conditions. The campaign utilizes the COVID pandemic as a motivating force to give up smoking. I COVID Quit is funded by the Robert Wood Johnson Foundation for “Sustaining and Expanding the National Partnership on Behavioral Health and Tobacco Use.”
Funded by the Robert Wood Johnson Foundation, SCLC worked with Better World Advertising to develop a series of digital ads and videos of real individuals telling their unscripted stories of quitting smoking during the pandemic.
The digital images and videos can be found at ICOVIDQUIT.org and are FREE for your use! » learn moreFind more Cessation and Tobacco Control News in our Newsroom or go back to top.
Research Quitlines
Vinci C, Lam C, Schlechter CR, Shono Y, Vidrine JI, Wetter DW. Increasing Treatment Enrollment among Smokers who are not Motivated to Quit: A Randomized Clinical Trial. Transl Behav Med. 2022 Jan 18;12(1):ibab114. doi: 10.1093/tbm/ibab114. PMID: 34424337; PMCID: PMC8764989.
There is a significant research-to-practice gap with respect to reaching underserved populations with evidence-based tobacco cessation treatments. Increasing enrollment in evidence-based treatments is necessary to reduce tobacco use and tobacco-related health inequities. The purpose of the current study was to evaluate whether Motivation And Problem Solving (MAPS), a flexible, holistic counseling/navigation approach delivered via phone, and proactive provision of Nicotine Replacement Therapy (NRT) would improve Quitline enrollment among a sample of low SES smokers who were not motivated to quit. In a 3×2 factorial design, cigarette smokers (N = 603) were randomized to one of six treatment conditions (Standard Treatment, MAPS-6, or MAPS-12 by NRT or no NRT). Results indicated that both MAPS-6 and MAPS-12 increased Quitline enrollment compared to Standard Treatment (ps < .03). There were no differences between MAPS conditions. NRT did not increase Quitline enrollment. MAPS is an effective intervention with the potential to be disseminated and implemented in healthcare and community settings to increase the reach of evidence-based interventions for tobacco cessation. Tobacco CessationRigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J. Treatment of Tobacco Smoking: A Review. JAMA. 2022 Feb 8;327(6):566-577. doi: 10.1001/jama.2022.0395. PMID: 35133411. Importance. More deaths in the US are attributed to cigarette smoking each year than to any other preventable cause. Approximately 34 million people and an estimated 14% of adults in the US smoke cigarettes. If they stopped smoking, they could reduce their risk of tobacco-related morbidity and mortality and potentially gain up to 10 years of life. Observations. Tobacco smoking is a chronic disorder maintained by physical nicotine dependence and learned behaviors. Approximately 70% of people who smoke cigarettes want to quit smoking. However, individuals who attempt to quit smoking make an average of approximately 6 quit attempts before achieving long-term abstinence. Both behavioral counseling and pharmacotherapy while using nicotine replacement therapy (NRT) products, varenicline, or bupropion are effective treatments when used individually, but they are most effective when combined. In a meta-analysis including 19 488 people who smoked cigarettes, the combination of medication and behavioral counseling was associated with a quit rate of 15.2% over 6 months compared with a quit rate of 8.6% with brief advice or usual care. The EAGLES trial, a randomized double-blind clinical trial of 8144 people who smoked, directly compared the efficacy and safety of varenicline, bupropion, nicotine patch, and placebo and found a significantly higher 6-month quit rate for varenicline (21.8%) than for bupropion (16.2%) and the nicotine patch (15.7%). Each therapy was more effective than placebo (9.4%). Combining a nicotine patch with other NRT products is more effective than use of a single NRT product. Combining drugs with different mechanisms of action, such as varenicline and NRT, has increased quit rates in some studies compared with use of a single product. Brief or intensive behavioral support can be delivered effectively in person or by telephone, text messages, or the internet. The combination of a clinician's brief advice to quit and assistance to obtain tobacco cessation treatment is effective when routinely administered to tobacco users in virtually all health care settings. Conclusions and relevance. Approximately 34 million people in the US smoke cigarettes and could potentially gain up to a decade of life expectancy by stopping smoking. First-line therapy should include both pharmacotherapy and behavioral support, with varenicline or combination NRT as preferred initial interventions. Usidame B, Xie Y, Thrasher JF, et al. Differential Impact of the Canadian Point-of-sale Tobacco Display Bans on Quit Attempts and Smoking Cessation Outcomes by Sex, Income and Education: Longitudinal Findings from the ITC Canada Survey. Tobacco Control Published Online First: 11 January 2022. doi: 10.1136/tobaccocontrol-2021-056805. Significance. This study examines the differential effects of Canadian point-of-sale (POS) tobacco display bans across provinces on quit attempts and smoking cessation, by sex, education and income. Methods. We analysed survey data from five waves (waves 4–8) of the International Tobacco Control Canada Survey, a population-based, longitudinal survey, where provinces implemented display bans between 2004 and 2010. Primary outcomes were quit attempts and successful cessation. We used generalised estimating equation Poisson regression models to estimate associations between living in a province with or without a POS ban (with a 24-month threshold) and smoking outcomes. We tested whether these associations varied by sex, education and income by including interaction terms. Results. Across survey waves, the percentage of participants in provinces with POS bans established for more than 24 months increased from 5.0% to 95.8%. There was no association between POS bans and quit attempts for provinces with bans in place for 0–24 months or more than 24 months, respectively (adjusted relative risk (aRR)=0.99, 95% CI: 0.89 to 1.10; 1.03, 95% CI: 0.88 to 1.20). However, we found a differential impact of POS bans on quit attempts by sex, whereby bans were more effective for women than men for bans of 0–24 months. Participants living in a province with a POS ban for at least 24 months had a higher chance of successful cessation (aRR=1.49; 95% CI: 1.08 to 2.05) compared with those in a province without a ban. We found no differences in the association between POS bans and quit attempts or cessation by education or income, and no differences by sex for cessation. Conclusion. POS bans are associated with increased smoking cessation overall and more quit attempts among women than men. Priority PopulationsBold KW, Cannon S, Ford BB, Neveu S, Sather P, Toll BA, Fucito LM. Examining Tobacco Treatment Perceptions and Barriers among Black vs. non-Black Adults Attending Lung Cancer Screening. Cancer Prev Res (Phila). 2022 Jan 21:canprevres.CAPR-21-0398-A.2021. doi: 10.1158/1940-6207.CAPR-21-0398. Epub ahead of print. PMID: 35063942.
The US Preventive Services Task Force recommends annual lung cancer screening for patients at high risk based on age and smoking history. Understanding the characteristics of patients attending lung cancer screening, including potential barriers to quitting smoking, may inform ways to engage these high-risk patients in tobacco treatment and address health disparities. Patients attending lung cancer screening who currently smoke cigarettes completed a survey at Smilow Cancer Hospital at Yale-New Haven (N=74) and the Medical University of South Carolina (N=73) at the time of their appointment. The survey assessed demographics, smoking history, and perceptions and concerns about quitting smoking. Patients were 55-76 years old (M=63.3, SD=5.3), N=64 (43.5%) female, and N=31 (21.1%) non-Hispanic Black. Patients smoked 16.3 cigarettes per day on average (SD=9.2) and rated interest in quitting smoking in the next month as moderate (M=5.6, SD=3.1, measured from 0="very definitely no" to 10="very definitely yes"). The most frequently endorsed concerns about quitting smoking were missing smoking (70.7%), worry about having strong urges to smoke (63.9%), and concerns about withdrawal symptoms (59.9%). Compared to other race/ethnicities, Black patients were less likely to report concerns about withdrawal symptoms and more likely to report smoking less now and perceiving no need to quit. Findings identified specific barriers for tobacco treatment and differences by race/ethnicity among patients attending lung cancer screening, including concerns about withdrawal symptoms and perceived need to quit. Identifying ways to promote tobacco treatment is important for reducing morbidity and mortality among this high-risk population.
Mills SD, Kong AY, Reimold AE, Baggett CD, Wiesen CA, Golden SD. Sociodemographic Disparities in Tobacco Retailer Density in the United States, 2000 - 2017. Nicotine Tob Res. 2022 Jan 25:ntac020. doi: 10.1093/ntr/ntac020. Epub ahead of print. PMID: 35079790.
Introduction. Studies find differences in tobacco retailer density according to neighborhood sociodemographic characteristics, raising issues of social justice, but not all research is consistent. This study examined associations between tobacco retailer density and neighborhood sociodemographic characteristics in the United States (US) at four timepoints (2000, 2007, 2012, 2017) and investigated if associations remained stable over time. Methods. Data on tobacco retailers came from the National Establishment Time-Series Database. Adjusted log-linear models examined the relationship between retailer density and census tract sociodemographic characteristics (% non-Hispanic Black [Black], % Hispanic, % vacant housing units, median household income), controlling for percentage of youth, urbanicity and US region. To examine whether the relationship between density and sociodemographic characteristics changed over time, additional models were estimated with interaction terms between each sociodemographic characteristic and year. Results. Tobacco retailer density ranged from 1.22-1.44 retailers/1,000 persons from 2000 to 2017. There were significant, positive relationships between tobacco retailer density and the percentage of Black (standardized exp(b)=1.05 (95% CI: 1.04, 1.07) and Hispanic (standardized exp(b)=1.06 (95% CI: 1.05, 1.08) residents and the percentage of vacant housing units (standardized exp(b)=1.08 (95% CI: 1.07, 1.10) in a census tract. Retailer density was negatively associated with income (standardized exp(b)=0.84 (95% CI: 0.82, 0.86). From 2000 to 2017, the relationship between retailer density and income and vacant housing units became weaker. Conclusions. Despite the weakening of some associations, there are sociodemographic disparities in tobacco retailer density from 2000 to 2017, which research has shown may contribute to inequities in smoking. Implications. This study examines associations between tobacco retailer density and neighborhood sociodemographic characteristics in the United States at four time points from 2000 to 2017. Although some associations weakened, there are sociodemographic disparities in tobacco retailer density over the study period. Research suggests that sociodemographic disparities in retailer density may contribute to inequities in smoking. Findings from this study may help identify which communities should be prioritized for policy intervention and regulation. E-Cigarettes and Heated Tobacco Products Rest EC, Brikmanis KN, Mermelstein RJ. Preferred Flavors and Tobacco Use Patterns in Adult Dual Users of Cigarettes and ENDS. Addict Behav. 2022 Feb;125:107168. doi: 10.1016/j.addbeh.2021.107168. Epub 2021 Oct 30. PMID: 34772504; PMCID: PMC8629959.
Objectives. This study examined how adult dual users of cigarettes and electronic nicotine delivery system (ENDS) flavor preference varied by demographics, tobacco history, motives, and expectancies for ENDS, and how ENDS flavor preference was associated with changes in cigarette and ENDS use over 12 months. Methods. Data come from the baseline and 12-month waves of an observational study of adult dual cigarette and ENDS users (N = 406). Flavor preferences were grouped into 4 categories: tobacco (12.6%), menthol/mint (34.7%), sweet (44.8%), and other (7.9%). Results. Users of sweet-flavored ENDS were significantly younger than those who used tobacco- or menthol flavors. Black dual users were significantly more likely than other racial groups to use menthol and less likely to use sweet flavors. Dual users who preferred sweet flavors smoked cigarettes on fewer days than those who preferred tobacco and menthol flavors, were less cigarette dependent, more strongly endorsed boredom reduction expectancies and motives related to taste and sensory experience and were more likely to stop smoking by 12 months. Conclusions. Dual users of cigarettes and ENDS who preferred sweet flavored ENDS differed in demographics, tobacco history, motives, expectancies, and smoking changes. Findings have implications for interventions and regulations.
Li W, Osibogun O, Li T, Sutherland MT, Maziak W. Changes in Harm Perception of ENDS and Their Predictors Among US Adolescents: Findings from the Population Assessment of Tobacco and Health (PATH) Study, 2013-2018. Prev Med. 2022 Feb;155:106957. doi: 10.1016/j.ypmed.2022.106957. Epub 2022 Jan 21. PMID: 35065977.
Electronic nicotine delivery systems (ENDS) use has dramatically increased in the US. This study aimed to characterize changes in ENDS harm perception over time and associated predictors among US adolescents. Data from the 2013-2018 Population Assessment of Tobacco and Health Study (PATH) for adolescents (12-17 years) were utilized. Trend analyses were employed to delineate changes in comparative and absolute ENDS harm perception over a four-year interval. We applied a time-varying effect model (TVEM) to examine the associations between the changes in harm perception and associated predictors. The results suggest that perception of ENDS as less harmful than cigarettes significantly decreased from 54.3% at Wave 1 (2013) to 30.4% at Wave 4 (2018) (P < 0.001). Perception of ENDS as no or little harm decreased from 35.9% at Wave 1 to 16.9% at Wave 4 (P < 0.001). These changes in harm perception were less robust among males, adolescents who did not have positive tobacco-related attitudes, and those with smoke-free home rules (P's < 0.05). Additionally, having ever used ENDS or alcohol were more likely to be associated with reduced ENDS-related harm perception over time (P's < 0.05). Our results show that while ENDS-related harm perception have generally increased, this does not appear to be equally experienced across all adolescents, potentially highlighting the importance of at-risk groups and targets for intervention. This study can help identify individuals at risk of ENDS initiation because of their favorable ENDS harm perception profile, as well as guide the development of ENDS risk communication interventions for adolescents.
Chen R, Pierce JP, Leas EC, et al. Effectiveness of E-cigarettes as Aids for Smoking Cessation: Evidence from the PATH Study Cohort, 2017–2019. Tobacco Control Published Online First: 07 February 2022. doi: 10.1136/tobaccocontrol-2021-056901
Objective. To assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette sales. Methods. In 2017, the PATH Cohort Study included data on 3578 previous year smokers with a recent quit attempt and 1323 recent former smokers. Respondents reported e-cigarettes or other products used to quit cigarettes and many covariates associated with e-cigarette use. Study outcomes were 12+ months of cigarette abstinence and tobacco abstinence in 2019. We report weighted unadjusted estimates and use propensity score matched analyses with 1500 bootstrap samples to estimate adjusted risk differences (aRD). Results. In 2017, 12.6% (95% CI 11.3% to 13.9%) of recent quit attempters used e-cigarettes to help with their quit attempt, a decline from previous years. Cigarette abstinence for e-cigarette users (9.9%, 95% CI 6.6% to 13.2%) was lower than for no product use (18.6%, 95% CI 16.0% to 21.2%), and the aRD for e-cigarettes versus pharmaceutical aids was −7.3% (95% CI −14.4 to –0.4) and for e-cigarettes versus any other method was −7.7% (95% CI −12.2 to –3.2). Only 2.2% (95% CI 0.0% to 4.4%) of recent former smokers switched to a high nicotine e-cigarette. Subjects who switched to e-cigarettes appeared to have a higher relapse rate than those who did not switch to e-cigarettes or other tobacco, although the difference was not statistically significant. Conclusions. Sales increases in high nicotine e-cigarettes in 2017 did not translate to more smokers using these e-cigarettes to quit smoking. On average, using e-cigarettes for cessation in 2017 did not improve successful quitting or prevent relapse.
Technology
Bendotti H, Lawler S, Ireland D, Gartner C, Hides L, Marshall HM. What do People Want in a Smoking Cessation App? An Analysis of User Reviews and App Quality. Nicotine Tob Res. 2022 Feb 1;24(2):169-177. doi: 10.1093/ntr/ntab174. PMID: 34460922.
Introduction. Mobile smoking cessation (mCessation) apps have the potential to complement and enhance existing interventions, but many are of low quality. Exploring app reviews can provide a broader understanding of user experiences and engagement, to enhance the quality, acceptability, and effectiveness of future developments. Methods. Publicly available user reviews and ratings of smoking cessation apps were mined from Google Play and the App Store via a targeted two-stage search strategy. English language smoking cessation apps with at least 20 consumer reviews between 2011 and 2020 were included. User reviews were thematically analyzed using Braun and Clarke's framework. Apps were independently scored using the Mobile Apps Rating Scale (MARS) and compared to average user star ratings. Results. Forty-eight versions of 42 apps, encompassing 1414 associated reviews, met eligibility criteria. Inductive coding of reviews produced 1084 coding references including reviews coded across multiple nodes. Themes generated included: (1) supportive characteristics/tools; (2) useability; (3) influence on smoking behavior; (4) benefits of quitting; and (5) role as a supplementary tool for quitting. The mean MARS score of 36 free and accessible apps was 3.10 (SD 0.71) with mean scores ranging from 2.00 to 4.47. An inverse relationship between MARS scores and average user star ratings was observed. Conclusions. App personalization, relationality, functionality, and credibility were important to users, and should be considered as key design components for future apps. Differences between user star ratings and MARS scores may illustrate competing priorities of consumers and researchers, and the importance of a codesign development method. Implications. This is the first study to use unsolicited user reviews from a large population to understand the general mCessation user experience in relation to making a quit attempt. Our findings highlight specific features favored and disliked by users, including their influence on engagement, and supports previous findings that mCessation applications need to be highly tailorable, functional, credible, and supportive. We recommend a consumer-driven, co-design approach for future mCessation app developments to optimize user acceptability and engagement.
Christofferson DE, Blalock DV, Knoeppel J, Beckham JC, Hamlett-Berry K, Hertzberg JS. A Real-world Evaluation of a Smokeless Tobacco Cessation Text Message Program for Veterans: Outcomes and Comparison to Cigarette Smokers. Nicotine Tob Res. 2022 Feb 1;24(2):186-195. doi: 10.1093/ntr/ntab191. PMID: 34545940.
Introduction. Smokeless tobacco (ST) use and cessation rates have remained unchanged while cigarette smoking has declined, and cessation rates have increased. Text message programs have proved effective for cigarette smokers but have not been evaluated for ST users. The Veterans Health Administration (VHA) created a ST-specific arm of its SmokefreeVET automated text message program to help veteran ST users quit. Aims and methods. A retrospective evaluation was conducted on a real-world sample of veteran ST users (n = 1139) who subscribed to SmokefreeVET between 2017 and 2020. Time in program, abstinence, and nicotine replacement therapy (NRT) use were evaluated and compared to 9764 cigarette smokers who subscribed to SmokefreeVET. Results. Younger subscribers were more likely to opt out early; 54% of ST users and 60% of cigarette smokers completed the 6-week program. ST users were more likely to report abstinence than cigarette smokers at all time points: the primary outcome, 30-day abstinence at 6 months, was 3.9% in ST users and 2.6% in cigarette smokers (p = .05) and the secondary outcome, abstinence at 3 months, was 5.3% in ST users and 3.4% in cigarette smokers (p = .03). NRT was used by 17% of ST users and was associated with a trend toward higher abstinence compared to ST users who did not use NRT. Conclusion. A real-world sample of ST users were more likely to report abstinence after using the SmokefreeVET text program than cigarette smokers. Automated text message programs may be effective for increasing cessation among ST users and warrant further investigation. Implications. Smokeless tobacco (ST) cessation is an important public health priority and of importance for veteran and military populations that have higher rates of ST use. There have been relatively few studies conducted investigating the effectiveness of text message interventions for ST cessation, despite the proven efficacy for cigarette smokers. This study provides evidence from a large, real-world sample that text message programs may be effective for ST users and suggests that further research into this treatment modality for ST users is needed.
Tobacco Use
Buckell J, Fucito LM, Krishnan-Sarin S, O'Malley S, Sindelar JL. Harm Reduction for Smokers with Little to no Quit Interest: Can Tobacco Policies Encourage Switching to E-cigarettes? Tob Control. 2022 Jan 19:tobaccocontrol-2021-057024. doi: 10.1136/tobaccocontrol-2021-057024. Epub ahead of print. PMID: 35046127.
Objective. A pressing tobacco policy concern is how to help smokers who have little interest in quitting cigarettes, a group that often suffers severe health consequences. By switching from cigarettes to e-cigarettes, they could obtain nicotine, potentially with less harm. We examined if policy-relevant attributes of cigarettes/e-cigarettes might encourage these smokers to switch to e-cigarettes. Methods. An online survey and discrete choice experiment on a nationally-representative sample of adult smokers in the US who reported low interest in quitting (n=2000). We modelled preference heterogeneity using a latent class, latent variable model. We simulated policies that could encourage switching to e-cigarettes. Results. Participants formed two latent classes: (1) those with very strong preferences for their own cigarettes; and (2) those whose choices were more responsive to policies. The latter group's choices were only somewhat responsive to menthol cigarette bans and taxes; the former group's choices were unresponsive. Conclusions. The policies studied seem unlikely to encourage harm reduction for individuals with little interest in quitting smoking.
Loud EE, Duong HT, Henderson KC, Reynolds RM, Ashley DL, Thrasher JF, Popova L. Addicted to Smoking or Addicted to Nicotine? A Focus Group Study on Perceptions of Nicotine and Addiction among US Adult Current Smokers, Former Smokers, Non-smokers and Dual Users of Cigarettes and E-cigarettes. Addiction. 2022 Feb;117(2):472-481. doi: 10.1111/add.15634. Epub 2021 Jul 20. PMID: 34227709; PMCID: PMC8733050.
Background and aims. In 2017, the US Food and Drug Administration (FDA) proposed to reduce nicotine in cigarettes to minimally or non-addictive levels. This study qualitatively explored perceptions of nicotine and addiction, both independently and in response to messages communicating about nicotine reduction. Design. Qualitative study using focus groups. Participants described their perceptions of nicotine and addiction and their responses to messages about the nicotine reduction. Setting. Atlanta, GA and San Francisco, CA, USA. Semi-structured focus groups were conducted virtually in Spring 2020. Participants. Exclusive smokers (n = 27), dual users (of cigarettes and electronic cigarettes) (n = 25), former smokers (n = 32) and young adult non-smokers (n = 31). Measurement. Inductive thematic analysis of transcripts was conducted, and results were compared across smoking status groups. Findings. Participants across all smoking status groups associated nicotine with tobacco products, but consistently misperceived that nicotine caused disease. Perceptions of addiction were largely negative and varied by smoking status. Experienced smokers (exclusive smokers, former smokers and dual users) differentiated tobacco use from other addictions and minimized their own experiences of addiction. Perceptions of addiction across experienced smokers included not only the chemical properties of nicotine, but also the behavioral aspects of tobacco use, including oral fixation, having a smoking routine and response to internal and external cues. In response to messages, many believed that removing the nicotine would not make cigarettes less addictive because of the multi-factorial nature of smoking addiction that includes non-pharmacological cues. Conclusions. Perceptions of nicotine and addiction among non-smokers, former smokers, exclusive smokers and dual users of cigarettes and e-cigarettes vary based on smoking status, but there is a common tendency to believe that nicotine is addictive, that addiction results from more than just nicotine, and that very low nicotine cigarettes will not necessarily reduce the addictiveness of cigarettes.
COVID-19
Baker J, Krishnan N, Abroms LC, Berg CJ. The Impact of Tobacco Use on COVID-19 Outcomes: A Systematic Review. J Smok Cessat. 2022 Jan 20;2022:5474397. doi: 10.1155/2022/5474397. PMID: 35126740; PMCID: PMC8777389.
Introduction. Tobacco use increases risks for numerous diseases, including respiratory illnesses. We examined the literature to determine whether a history of tobacco use increases risks for adverse outcomes among COVID-19 patients. Methods. We conducted a systematic search of PubMed, LitCovid, Scopus, and Europe PMC (for preprints) using COVID-19 and tobacco-related terms. We included studies of human subjects with lab-confirmed COVID-19 infections that examined tobacco use history as an exposure and used multivariable analyses. The data was collected between March 31st, 2020, and February 20th, 2021. Outcomes included mortality, hospitalization, ICU admission, mechanical ventilation, and illness severity. Results. Among the 39 studies (33 peer-reviewed, 6 preprints) included, the most common outcome assessed was mortality (n = 32). The majority of these studies (17/32) found that tobacco use increased risk, one found decreased risk, and 14 found no association. Tobacco use was associated with increased risk of hospitalization in 7 of 10 studies, ICU admission in 6 of 9 studies, mechanical ventilation in 2 of 6 studies, and illness severity in 3 of 9 studies. One study found that tobacco use history increased risk of pulmonary embolism in COVID-19 patients. Tobacco use was found to compound risks associated with diabetes (n = 1), cancer (n = 2), and chronic liver disease (n = 1). Conclusion. There is strong evidence that tobacco use increases risks of mortality and disease severity/progression among COVID-19 patients. Public health efforts during the pandemic should encourage tobacco users to quit use and seek care early and promote vaccination and other preventive behaviors among those with a history of tobacco use.
Denlinger-Apte R, Suerken CK, Ross JC, Reboussin BA, Spangler J, Wagoner KG, Sutfin EL. Decreases in Smoking and Vaping During COVID-19 Stay-at-home Orders Among a Cohort of Young Adults in the United States. Prev Med. 2022 Feb 8:106992. doi: 10.1016/j.ypmed.2022.106992. Epub ahead of print. PMID: 35149114; PMCID: PMC8824729.
In Spring 2020, most US states and territories implemented stay-at-home orders to slow transmission of the novel coronavirus SARS-CoV2, the cause of COVID-19. Little is known about the impact of stay-at-home orders on tobacco and nicotine use including among young adults. The current study examined participants (N = 1727) completing three recent survey waves from a longitudinal cohort of young adults recruited in 2010 from North Carolina and Virginia, USA: Wave 13 (Spring 2019), Wave 14 (Fall 2019), and Wave 15 (Spring 2020) to assess changes in cigarette and e-cigarette use. We conducted logistic regression analyses to compare the odds that participants reported smoking or vaping in Wave 14 relative to Wave 13 to establish if there was a trend of use pre-pandemic. Then, we conducted logistic regression analyses to compare the odds that participants reported smoking or vaping in Wave 15 relative to Wave 14 to determine the impact of COVID-19 stay-at-home orders. When comparing the odds of reporting tobacco use at Wave 14 to Wave 13, no differences emerged (p > 0.05). However, when comparing tobacco use at Wave 15 to Wave 14, participants had 40% lower odds of reporting past 30-day cigarette use (p = 0.02) and 50% lower odds of reporting past 30-day e-cigarette use (p < 0.01). The current study provides initial evidence that young adults may have reduced their tobacco and nicotine use during the stay-at-home orders. However, more work is needed to determine the long-term impact of the COVID-19 pandemic on tobacco use and cessation in this population.
Job and Conference AnnouncementsIf you have any job openings that would interest tobacco control professionals, please send them to us at naqc@naquitline.org.AATCLC Recruiting for Communication Consultant (part-time).BackgroundFormed in 2008, the mission of the African American Tobacco Control Leadership Council (AATCLC) is to inform and influence the direction of commercial tobacco control as it affects the lives of African American and African Immigrant communities. The AATCLC works at the intersection of social injustice and public health policy. Working with health jurisdictions, elected officials, community-based organizations, tobacco researchers, activists and the media, the AATCLC has played a key role in elevating the once obscure issue of regulating the sale of menthol and flavored tobacco products to one of national concern and action. Please refer to these websites, www.savingblacklives.org, www.amplify.love, and www.centerforblackhealth.org/tobacco/ for background information. The RoleThe Communications Specialist is responsible for developing and executing the communications plan for the AATCLC. The Communications Specialist is responsible for drafting press releases, responding to breaking news/events in real time, maintaining media contact lists, developing and distributing an email newsletter, and maintaining an effective social media/web presence. Representative duties of the position include: ● Develop, implement, and evaluate the annual communications plan in collaboration with leadership ● Lead the creation of online content on AATCLC’s social media (YouTube, Twitter, Facebook, LinkedIn and others as relevant) that engages members and stakeholders and leads to measurable actions ● Act as liaison to print, online, and tv media as necessary, including creating and distributing press releases ● Manage relationships with contractors for website administration and design ● Coordinate webpage maintenance—ensure that new and consistent information (article links, stories, and events) is posted regularly ● Track, measure, and report constituent engagement across communications strategies ● Manage development, distribution, and maintenance of all print and electronic collateral, including, but not limited to, brochures, annual report, e-newsletters, and website ● Coordinate and lead team meetings with the goal of engaging all staff in communications strategies as appropriate Requirements:● Bachelor’s degree or equivalent professional experience;● Project management experience; ● Strong interpersonal, writing, and computer skills; ● Superb communication skills; ● Ability to work both independently and as a member of a team, manage details and meet established deadlines; ● Ability to work remotely and work across U.S. time zones Preferred Qualifications:● Demonstrated interest in working with organizations that intersect public health policy and social justice advocacy ● Demonstrated commitment to racial justice and health equity ● Familiar with tobacco control work and related issues, especially menthol regulation ● Experience working across diverse groups of stakeholders ● A sense of humor ● Flexibility Salary: This is a non-benefited, part-time consultant position. Pay rate is $40/hour minimum, but we are very open to negotiation above this based on skills and experience. How to apply: To be considered, applicants must send the following materials to alyssammouton@gmail.com. Job Opening in Nebraska - Tobacco Cessation Educator.Tobacco Free Nebraska is looking for a talented person to join their team for this position within Public Health. This person should be passionate about public health and helping Nebraskans quit tobacco and reducing tobacco-related death and disease. For more information, please visit the Public Health Webpage at the link below. » learn moreCity of Hope Job Opening - Tobacco Treatment Specialist (TTS) - Antelope Valley (Lancaster, CA).The Tobacco Treatment Specialist ("TTS") provides direct care to patients and education to patients and their families who currently use or have a history of tobacco use. The main goal of TTS is to increase the volume of high-risk oncology patients receiving tobacco/nicotine cessation services. TTS oversees the development of the clinical plan for tobacco dependent patients to improve integrative care and reduce/eliminate the tobacco burden and provide evidence-based tobacco treatment services. The TTS also collaborates with interdisciplinary team members for program referrals and care improvement. Job ID: 10013824 Job Title: Tobacco Treatment Specialist - Antelope Valley (Lancaster, CA) Job Link: hereMarch 22-23, 2022 Virtual Spring 2022 Tobacco Control Institute.The 2022 Spring Tobacco Control Institute will be held virtually via Zoom. Key topics: - National Tobacco Control Updates and Trends
- Priority Populations
- Health Equity
- Community Showcase
- …and more!
Learn more here. April 11-13, 2022 – NATCON.Registration for NatCon22 – the largest conference in mental health and substance use treatment – is now open! They are safely convening thousands of health care professionals, hundreds of sought-after speakers and dozens of industry-best organizations in the Washington, D.C., metro area for three days of unmatched learning, networking and entertainment. Join from April 11-13 to celebrate our resilience, reflect on the past and redefine the future of our field together. May 17-19, 2022 (New Orleans, Louisiana). The NNPHI Annual Conference is Coming Back!The National Network of Public Health Institutes (NNPHI) is proud to announce its 21st Annual Conference will be held May 17-19, 2022 in New Orleans, LA. For more information about the 2022 NNPHI Annual Conference contact convenings@nnphi.org or visit https://nnphi.org/annualconference/NCTOH 2022- June 28-30, 2022! (New Orleans, Louisiana)The National Conference on Tobacco or Health (NCTOH) is one of the largest, long-standing gatherings for top United States tobacco control professionals. The convening attracts a diversity of public health professionals committed to best practices and policies to reduce tobacco use—the leading preventable cause of disease and death in the United States. Learn more here. Find more Job and Conference Announcements in our Newsroom or go back to top.
Funding for Connections is provided solely through a cooperative agreement from the Centers for Disease Control and Prevention (5 NU58DP006704-03-00). We thank them for their support of this publication. Information and links are provided solely as a service to NAQC members and partners and do not constitute an endorsement of any organization by NAQC, nor should any be inferred. |